MINI REVIEW
Accepted on 07 Aug 2025
Cancer-Associated Fibroblasts in Osteosarcoma: Key Players in Immune Escape and Targeted Therapy
doi 10.3389/fimmu.2025.1668535
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Targeting cancer-associated fibroblasts: Disrupting immune evasion and therapy resistance
Targeting cancer-associated fibroblasts: Disrupting immune evasion and therapy resistance
1,143
Total downloads
7,054
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
MINI REVIEW
Accepted on 31 Jul 2025
The malignant dialogue between cancer-associated fibroblasts and osteosarcoma cells: Microenvironment-mediated drug resistance and therapeutic targets
doi 10.3389/fimmu.2025.1621521
- 116 views
MINI REVIEW
Published on 18 Jul 2025
Cancer-associated fibroblasts in hepatocellular carcinoma: origins, heterogeneity, and therapeutic implications
doi 10.3389/fimmu.2025.1620075
- 767 views
REVIEW
Published on 16 Jul 2025
Fibroblast activation protein and the tumour microenvironment: challenges and therapeutic opportunities
doi 10.3389/or.2025.1617487
- 944 views
MINI REVIEW
Accepted on 19 Jun 2025
Cancer-associated fibroblast-mediated immune evasion: Molecular mechanisms of stromal-immune crosstalk in the tumor microenvironment
doi 10.3389/fimmu.2025.1617662
- 276 views
MINI REVIEW
Published on 04 Jun 2025
Cancer-associated fibroblasts in clear cell renal cell carcinoma: functional heterogeneity, tumor microenvironment crosstalk, and therapeutic opportunities
doi 10.3389/fimmu.2025.1617968
- 2,518 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: